News
GlaxoSmithKline plc (UK) (($GB:GSK)) announced an update on their ongoing clinical study. GlaxoSmithKline (GSK) is ...
2d
TipRanks on MSNGSK’s Promising Study on Belimumab for Systemic Sclerosis Lung DiseaseGlaxoSmithKline plc (UK) (($GB:GSK)) announced an update on their ongoing clinical study. GlaxoSmithKline (GSK) is ...
Interstitial lung diseases (ILD) are a heterogenous group of over 200 irreversible conditions with varying degrees of inflammation that, without treatment, lead to scarring (fibrosis) of the ...
Stereotactic ablative radiotherapy (SABR) has been found to be a viable curative-intent treatment option among some patients with early-stage non-small cell lung cancer (NSCLC) and lung scarring known ...
SAN DIEGO — All patients with systemic sclerosis should be screened for pulmonary arterial hypertension and interstitial lung disease, according to a speaker at the 2024 Congress of Clinical ...
Interstitial Lung Disease (ILD), a condition characterised by inflammation and fibrosis, is a major cause of severe respiratory illness and can occur in children.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results